# US 2026/0092298 A1 · Bleomycin producing strain and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092298 A1
- Document ID: US20260092298A1
- Status: Published application
- Kind: A1
- Application number: 19/273,407
- Filed: 2025-07-18
- Published: 2026-04-02
- Earliest claimed: 2024-09-30
- Assignees: Hubei Honch Pharmaceutical Co.,Ltd
- Applicants: Hubei Honch Pharmaceutical Co.,Ltd
- Inventors: Renwen ZHANG; Wenkai ZHANG; Wei ZHENG; Jianye GAN; Hua DONG; Liyun KE; Li TIAN; Na JIANG; Fang HONG
- Web page: https://patentgrep.com/patent/US20260092298A1

## CPC

- C12P 21/005: {Glycopeptides, glycoproteins}
- C12N 1/20: Bacteria; Culture media therefor
- C12N 1/205: Bacterial isolates
- C12R 2001/465: Streptomyces
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

A production strain of bleomycin and its applications are provided. Through mutagenesis, a strain, Streptomyces mobaraensis BL-G2-202402, which exhibits high resistance to bleomycin, is obtained. Its deposit number is CCTCC NO: M 20241482. By adding bleomycin-backbone amino acids to its fermentation medium formula, the fermentation titer of bleomycin was increased, and the ratio of the main components bleomycin A2 and B2 was affected. When adding 0.5 g/L of bromogeramine and 2.5-10 g/L of oxygen-enhancing agent, the yield of bleomycin could be significantly increased. When using dried bacterial residue to replace part of the nitrogen source in the medium, it was found that fermentation titer increased if freeze-dried bacterial residue replace 10-40% of the corn steep powder as the nitrogen source for bleomycin fermentation.

## Claims

### Claim at position 1

1-10. (canceled)

### Claim 11

A strain of Streptomyces mobaraensis, wherein the strain is Streptomyces mobaraensis BL-G2-202402, with a deposit number: CCTCC NO: M 20241482.

### Claim 12 (depends on 11)

An application of the strain of the Streptomyces mobaraensis BL-G2-202402 according to claim 11 in a production of bleomycin.

### Claim 13 (depends on 12)

The application according to claim 12, wherein a method for producing the bleomycin comprises: inoculating seed liquid of the Streptomyces mobaraensis BL-G2-202402 into a fermentation medium at an inoculation amount of 10-20%, with a shaker rotation speed of 250-270 rpm, a cultivation temperature of 28-29° C., and a cultivation period of 8-10 d.

### Claim 14 (depends on 13)

The application according to claim 13, wherein the fermentation medium comprises: glucose 8-12 g/L, corn starch 30-50 g/L, sucrose 20-30 g/L, soybean cake powder 30-40 g/L, corn steep powder 15-20 g/L, zinc sulfate 1-1.5 g/L, and copper sulfate 0.02-0.05 g/L, with pH of 7.0.

### Claim 15 (depends on 14)

The application according to claim 14, wherein the fermentation medium further comprises 1 g/L of L-tryptophan, 1 g/L of DL-methionine, and 1 g/L of L-cysteine.

### Claim 16 (depends on 15)

The application according to claim 15, wherein the fermentation medium further comprises 0.5 g/L of bromogeramine and 2.5-10 g/L of an oxygen-enhancing agent; and the oxygen-enhancing agent is one of liquid paraffin, n-dodecane, or n-hexadecane.

### Claim 17 (depends on 16)

The application according to claim 16, wherein the fermentation medium comprises 0.5 g/L of the bromogeramine and 5 g/L of the n-hexadecane.

### Claim 18 (depends on 17)

The application according to claim 17, wherein in the fermentation medium, 10-40% of the corn steep powder is replaced with a dried bacterial residue of the Streptomyces mobaraensis BL-G2-202402.

### Claim 19 (depends on 18)

The application according to claim 18, wherein the dried bacterial residue is prepared by the following steps:
centrifuging a bleomycin fermentation broth of the Streptomyces mobaraensis BL-G2-202402 to obtain bacterial sludge, collecting the bacterial sludge, washing the bacterial sludge repeatedly with water to obtain residual bacteria, and then collecting and drying the residual bacteria to obtain a dried bacterial residue; and after drying, collecting the dried bacterial residue respectively and crushing the dried bacterial residue for later use.

### Claim 20 (depends on 19)

The application according to claim 19, wherein the drying is a high-temperature drying or a freeze-drying.
